Adult Immunization

Latest News

Of Vaccine Efficacy and COVID-19 Variants: 4 Questions / image credit ©coronavirus evolution: PX Media/stock.adobe.com
Of Vaccine Efficacy and COVID-19 Variants: 4 Questions

February 16th 2024

Just when the new monovalent COVID-19 vaccines were available in Sept 2023, a new variant emerged. Did the CDC get it right? What do you know about the monovalent VE?

GSK RSV Vaccine Arexvy Under FDA Priority Review for Prevention of RSV in High-Risk Adults Aged 50 to 59 Years / image credit GSK logo: ©desertlands/stock.adobe.com
GSK RSV Vaccine Arexvy Under FDA Priority Review for Prevention of RSV in High-Risk Adults Aged 50 to 59 Years

February 8th 2024

Two RSV Vaccines, One Savvy Patient who Asks, "Which One do You Recommend?" /  image credit vaccine vials ©Sherry Young/stock.adobe.com
Two RSV Vaccines, One Savvy Patient who Asks, "Which One do You Recommend?"

January 12th 2024

Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results / image credit moderna logo ©digitalskillet1/stock.adobe.com
Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results

January 8th 2024

FDA Grants Priority Review to Merck BLA for Investigational 21-Valent Pneumococcal Vaccine December 19, 2023
FDA Grants Priority Review to Merck BLA for Investigational 21-Valent Pneumococcal Vaccine

December 19th 2023

More News

© 2024 MJH Life Sciences

All rights reserved.